menu
    • menu

    Company profile for Tome Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tome Biosciences is a cutting-edge company specializing in programmable genomic integration (PGI). The company boasts technologies that enable the precise insertion of genetic sequences of any size at any location in the genome. With a focus on site-specific precision, Tome Biosciences is at the forefront of genomic medicine, paving the way for revolutionary cell and integrative gene therapies to provide cures for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tome BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    AOTC, Watertown, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tome.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tome-biosciences/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tome_bio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Preclinical Gene Editor Tome Laying Off 131 Staffers, Entire Workforce
    Preclinical Gene Editor Tome Laying Off 131 Staffers, Entire Workforce

    26 Aug 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/preclinical-gene-editor-tome-laying-131-staffers-virtually-entire-workforce

    FIERCE BIOTECH
    26 Aug 2024
    Share Share
    Gene Editing Biotech Tome Shrinks Operations After $213M Round
    Gene Editing Biotech Tome Shrinks Operations After $213M Round

    22 Aug 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/young-gene-editing-biotech-explores-strategic-options-investors-pullback

    FIERCE BIOTECH
    22 Aug 2024
    Share Share
    Tome Programmable Genomic Integration At ASGCT
    Tome Programmable Genomic Integration At ASGCT

    10 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/10/2879477/0/en/Tome-Biosciences-Presented-Data-on-its-Programmable-Genomic-Integration-Technologies-at-ASGCT.html

    GLOBENEWSWIRE
    10 May 2024
    Share Share
    Tome Presenting Genomic Integration Technologies At ASGCT
    Tome Presenting Genomic Integration Technologies At ASGCT

    23 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/23/2867592/0/en/Tome-Biosciences-to-Present-Data-on-Programmable-Genomic-Integration-Technologies-at-ASGCT.html

    GLOBENEWSWIRE
    23 Apr 2024
    Share Share
    Tome Biosciences granted US patent for genomic integration
    Tome Biosciences granted US patent for genomic integration

    09 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/09/2859969/0/en/Tome-Biosciences-Announces-US-Patent-Issued-for-Integrase-Mediated-Programmable-Genomic-Integration.html

    GLOBENEWSWIRE
    09 Apr 2024
    Share Share
    Tome Biosciences Forms Science and Technology Advisory Committee
    Tome Biosciences Forms Science and Technology Advisory Committee

    04 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/04/2839513/0/en/Tome-Biosciences-Forms-Science-and-Technology-Advisory-Committee.html

    GLOBENEWSWIRE
    04 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search